TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT02290145

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TPF group
Description: The patients in the experimental group received the TPF induction chemotherapy for 2 cycles followed by radical surgery and post-operative radiotherapy.~docetaxel:75mg/m2 cisplatin：75 mg/m2 5-Fu：750 mg/m2/day

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: surgery group
Description: The patients in the control group received the radical surgery and post-operative radiotherapy.

Intervention type: PROCEDURE
Group type: OTHER
Intervention: surgery group
Description: The patients in the control group received the radical surgery and post-operative radiotherapy.

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Post-operative radiotherapy
Description: Radiotherapy was arranged 4 to 6 weeks after surgery. Routine external beam radiotherapy, such as conformal or intensity modulated radiotherapy was performed, and the dose was 1.8-2 Gy/day, 5 days/week for 6 weeks, and totally 54-60 Gy.
Study: NCT03535805

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Treatment as Usual (TAU)
Description: The parents in the TAU group are offered two sessions (week 2 and week 17) to support their attempts to seek help for the child in the municipality. This coordination is provided by psychologists (or other local professionals) who hold records of the currently available treatment options in the municipality. The TAU vary considerably from no intervention to counselling, talk therapy, pedagogical advice, network meetings, and/or individual support in the school setting. Some children are offered CBT interventions, but access to manualized treatment is generally very limited.
Study: NCT01068288

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Laparoscopic or open appendectomy

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Expectant Management
Description: A consult to Interventional Radiology will be made at the time of admission to determine whether percutaneous drainage is feasible, and if it is the abscess will be drained by Interventional Radiology. Ultrasound and/or CT scan will be used to follow the abscess collections and/or phlegmons and guide the removal of drains.~For patients with a fecalith on imaging, a laparoscopic interval appendectomy will be performed 6-12 weeks following discharge from hospital. For those without a fecalith on imaging, a decision will be made by the family, with the guidance of the surgeon, whether or not to undergo a laparoscopic interval appendectomy.
Study: NCT00069381

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psychotherapy treatment
Study: NCT03413215

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intensive
Description: Patients are provided with a BP machine, glucometer and test strips, and instructed how to use either a written or smartphone logbook, photograph their meals and use smartphone apps to measure daily activity. DNEs will contact patients in between visits to reinforce adherence and self-monitoring.~MSWs will conduct at least 6 face-to-face sessions, at 3 weeks then less frequently, on essential self-care behaviours in people with diabetes: healthy eating; being physically active; monitoring of blood sugar; compliance with medications; problem-solving; healthy coping skills; and risk-reduction behaviour.~Renal pharmacists will see patients at 2-4 week intervals for 3 months after the first clinic visit, and subsequently every 3-6 months. They will review patient's compliance, laboratory results and home BP, educate patient and titrate antihypertensives to meet BP goal. Physician referrals will be made for severe hypertension or hypotension, or intolerable side effects.
Study: NCT02290145

Intervention type: RADIATION
Group type: OTHER
Intervention: Post-operative radiotherapy
Description: Radiotherapy was arranged 4 to 6 weeks after surgery. Routine external beam radiotherapy, such as conformal or intensity modulated radiotherapy was performed, and the dose was 1.8-2 Gy/day, 5 days/week for 6 weeks, and totally 54-60 Gy.
Study: NCT00332306

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Didanosine, Lamivudine, Efavirenz
Description: Didanosine 250mg patients \<60kg, 400mg patients \> 60kg once daily Lamivudine 300 mg once daily Efavirenz 600 mg once daily All drugs will be given for 24 months

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Didanosine, Lamivudine, Nevirapine
Description: Didanosine 250 mg once daily for patients \< 60kg, 400 mg OD patients \> 60kg Lamivudine 300 mg once daily Nevirapine 400 mg once daily All drugs will be given for 24 months
Study: NCT04261010

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Global/single cell gene expression profiles obtained from Synovial biopsies
Description: Global/single cell gene expression profiles obtained from synovial biopsies before and after 24 weeks of treatment with the drug.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Global/single cell gene expression profiles obtained from Synovial biopsies
Description: Global/single cell gene expression profiles obtained from synovial biopsies before and after 24 weeks of treatment with the drug.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Global/single cell gene expression profiles obtained from Synovial biopsies
Description: Global/single cell gene expression profiles obtained from synovial biopsies before and after 24 weeks of treatment with the drug.
Study: NCT01014481

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: tenofovir, lamivudine, efavirenz
Description: initiate tenofovir 300 mg/day, lamivudine 300 mg/day, efavirenz 600 mg/day between at 4 weeks and at 12 weeks after tuberculosis treatment
Study: NCT04644159

Intervention type: OTHER
Intervention: Human biological samples
Description: Blood , saliva, nasopharyngeal mucosa

Intervention type: OTHER
Intervention: Human biological samples
Description: Blood , saliva, nasopharyngeal mucosa

Intervention type: OTHER
Intervention: Human biological samples
Description: Blood , saliva, nasopharyngeal mucosa
Study: NCT04876976

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyanoacrylate, Isobutyl
Description: using cyanoacrylate in the surgical repair of urethro-cutaneous fistula

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Classic surgical repair
Description: classical repair of urethro-cutaneous fistula without the use of cyanoacryalte
Study: NCT02742675

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bicalutamide
Description: Given orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bicalutamide
Description: Given orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: goserelin acetate
Description: Given subcutaneously or as an injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: goserelin acetate
Description: Given subcutaneously or as an injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: flutamide
Description: Given orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: flutamide
Description: Given orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: leuprolide acetate
Description: Given subcutaneously or as an injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: leuprolide acetate
Description: Given subcutaneously or as an injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: triptorelin
Description: Given subcutaneously or as an injection

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: triptorelin
Description: Given subcutaneously or as an injection

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Definitive Treatment
Description: surgery to remove prostate or radiation therapy to the prostate.
Study: NCT04153968

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: β-cryptoxanthin
Description: Phase 1:~2.0mg of \[13C14\]β-cryptoxanthin, 1.0mg of \[13C10\]β-carotene and 0.4mg \[2H6\]retinyl acetate are given in sunflower oil at Time 0.~Phase 2:~1.5mg of \[13C14\]β-cryptoxanthin, 0.75mg of \[13C10\]β-carotene, 0.4mg \[2H6\]retinyl acetate are given in sunflower oil along with 0.25mg β-carotene and 0.5mg β-cryptoxanthin from maize are given at Time 0.~Then, 0.75mg of \[13C14\]β-cryptoxanthin, 1.5mg of \[13C10\]β-carotene, and 0.4mg \[2H6\]retinyl acetate are given in sunflower oil along with 0.5mg β-carotene and 0.25mg β-cryptoxanthin from maize are given on day 21.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: β-cryptoxanthin
Description: Phase 1:~2.0mg of \[13C14\]β-cryptoxanthin, 1.0mg of \[13C10\]β-carotene and 0.4mg \[2H6\]retinyl acetate are given in sunflower oil at Time 0.~Phase 2:~1.5mg of \[13C14\]β-cryptoxanthin, 0.75mg of \[13C10\]β-carotene, 0.4mg \[2H6\]retinyl acetate are given in sunflower oil along with 0.25mg β-carotene and 0.5mg β-cryptoxanthin from maize are given at Time 0.~Then, 0.75mg of \[13C14\]β-cryptoxanthin, 1.5mg of \[13C10\]β-carotene, and 0.4mg \[2H6\]retinyl acetate are given in sunflower oil along with 0.5mg β-carotene and 0.25mg β-cryptoxanthin from maize are given on day 21.
Study: NCT02907775

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: ShefStim
Description: Electrode arrays will be worn over the affected arm with stimulation applied over the extensor aspect of the upper arm

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Electrodes
Description: electrodes placed over the radial nerve in radial grove
Study: NCT03246919

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oxytocin
Description: Oxytocin is administered after delivery of the fetal anterior shoulder, rather than being administered after delivery of the placenta

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo will be administered after delivery of the placenta
Study: NCT02768922

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aphasia telerehabilitation
Description: Speech and language therapy delivered by speech-language pathologist via computer and telemedicine

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard face-to-face aphasia rehabilitation
Description: Speech and language therapy delivered by speech-language pathologist face-to-face (treatment as usual)

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard face-to-face aphasia rehabilitation
Description: Speech and language therapy delivered by speech-language pathologist face-to-face (treatment as usual)
Study: NCT03707834

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Antenatal Obesity Treatment (AO)
Description: Participants in the treatment (AO) arm will receive a 4-component intervention: 1)Behavior change goals; 2)Self-monitoring; 3)Tailored skills training; and 4)WIC provider counseling Both treatment and usual care arms will receive the current standard of care offered to postpartum mothers at WIC.
Study: NCT00590538

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sodium 4-Phenylbutyrate
Description: The standard oral adult dose is 20 g/day (tablets) for 4 days.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Genistein (Unconjugated Isoflavones 100)
Description: Every participant will be administered a perfusion of 50 MicroM of Genistein (Unconjugated Isoflavones 100) during the modified NPD procedure.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Genistein (Unconjugated Isoflavones 100)
Description: Every participant will be administered a perfusion of 50 MicroM of Genistein (Unconjugated Isoflavones 100) during the modified NPD procedure.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The placebo is given to match the active comparator for four days.
Study: NCT04131491

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Lumbar puncture
Description: Lumbar puncture for AD biomarker fluid analysis

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Lumbar puncture
Description: Lumbar puncture for AD biomarker fluid analysis
Study: NCT02667626

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Reproductive Health Survivorship Care Plan (SCPR)
Description: The reproductive health survivorship care plan (SCPR) is a web-based educational tool that will include information on how to manage various reproductive health issues such as hot flashes, fertility concerns, contraception practices, and sexual function. The intervention also includes additional web-based information and resource lists, text-based reproductive health and study adherence prompts.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: Web-based resource lists and text-based study adherence reminders
Study: NCT03609957

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aerobic Exercise Training
Description: Traditional, continuous aerobic exercise (cycling) at a moderate intensity

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Interval Training
Description: High-intensity interval exercise consisting of short bursts of exercise interspersed with rest periods
Study: NCT02444039

Intervention type: DEVICE
Intervention: SL-D301
Description: Slit Lamp

Intervention type: DEVICE
Intervention: DC-4
Description: Digital Camera Attachment

Intervention type: DEVICE
Intervention: SL-3G
Description: Slit Lamp
Study: NCT03726736

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anlotinib combined Docetaxel
Description: Anlotinib ( dose base on phase I study, QD PO d1-14, 21 days per cycle) and Docetaxel (60mg/m2 IV, d1, 21 days per cycle)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Docetaxel
Description: Docetaxel (60mg/m2 IV, d1, 21 days per cycle)
Study: NCT02451397

Intervention type: OTHER
Description: This is a cross-sectional study, and we do not assign specific interventions to the subjects of the study.
Study: NCT03787199

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Andago
Description: The Andago is a body-weight supporting device with which a patient can walk overground

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Treadmill
Description: Bodyweight supported treadmill walking
Study: NCT04100590

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cannabis
Description: Smoked active cannabis (7% THC) vs. placebo inactive cannabis (0% THC)

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Cannabis
Description: Smoked active cannabis (7% THC) vs. placebo inactive cannabis (0% THC)
Study: NCT02179476

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Glyder
Description: The Glyder Facet Restoration Device is intended for minimally invasive bilateral implantation in one or two lumbar facet levels
Study: NCT00576004

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Pelvic organ prolapse repair and Burch colposuspension
Description: Abdominal pelvic organ prolapse repair and retropubic Burch colposuspension

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Pelvic organ prolapse repair and Burch colposuspension
Description: Abdominal pelvic organ prolapse repair and retropubic Burch colposuspension
Study: NCT01768221

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Caregiver Intervention
Description: Participants will speak with a chaplain for three brief, 45 minute to one hour, sessions.~The sessions will focus on topics of relationship life review, unresolved conflicts and issues of forgiveness, and future goals, lessons learned and legacy.~In the week following the third session, the chaplain will call participants for a brief check in. This call will include no new intervention content, rather it provides an opportunity for participants to mention any additional thoughts or concerns they want to discuss with the chaplain interventionist.
Study: NCT00723697

Intervention type: DRUG
Intervention: buprenorphine
Description: 0.4, 2, or 8 mg sublingual tablets
Study: NCT02724410

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: home intravenous ertapenem
Description: see arm description

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: home oral amoxicillin-clavulanate
Description: see arm description

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: peripheral inserted central Catheter
Description: All patients undergoing home intravenous ertapenem will require placement of peripheral inserted central Catheter (PICC) for home delivery of antibiotics.
Study: NCT01063231

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PillCam™ (Capsule Endoscopy) Colon 2 capsule
Description: Medical Device
Study: NCT04293835

Intervention type: DIAGNOSTIC_TEST
Intervention: Whether to have intestinal-related disease
Description: All patients pathologically diagnosed with sigmoid or rectal cancer in Peking University Third Hospital from January 2010 to December 2018 were included in our study as the cancer group.To evaluate the relationship between the height of the sigmoid take-off and all baseline covariates in normal patients, the results of 200 patients without any intestinal-related abnormalities who underwent pelvic MRI in our center from January 2019 to June 2019 were reviewed as a normal group.
Study: NCT03576352

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: a rapid sequence tracheostomy (RST) on rabbit cadaver
Description: The Rapid Sequence Tracheostomy (RST) consists of the following steps:~1. Orientational palpation and vertical midline skin incision followed by separation of the strap muscles~2. Exposure of the trachea and cricoid followed by anterior luxation of the trachea with a Backhaus towel clamp~3. Perform a vertical puncture with a tip scissors between the Cricoid and 1st tracheal ring followed by a vertical incision of no more than 2 rings in length.~4. An age adapted tracheal tube is inserted into the trachea and the lungs are ventilated.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: a rapid sequence tracheostomy (RST) on rabbit cadaver
Description: The Rapid Sequence Tracheostomy (RST) consists of the following steps:~1. Orientational palpation and vertical midline skin incision followed by separation of the strap muscles~2. Exposure of the trachea and cricoid followed by anterior luxation of the trachea with a Backhaus towel clamp~3. Perform a vertical puncture with a tip scissors between the Cricoid and 1st tracheal ring followed by a vertical incision of no more than 2 rings in length.~4. An age adapted tracheal tube is inserted into the trachea and the lungs are ventilated.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: a rapid sequence tracheostomy (RST) on rabbit cadaver
Description: The Rapid Sequence Tracheostomy (RST) consists of the following steps:~1. Orientational palpation and vertical midline skin incision followed by separation of the strap muscles~2. Exposure of the trachea and cricoid followed by anterior luxation of the trachea with a Backhaus towel clamp~3. Perform a vertical puncture with a tip scissors between the Cricoid and 1st tracheal ring followed by a vertical incision of no more than 2 rings in length.~4. An age adapted tracheal tube is inserted into the trachea and the lungs are ventilated.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: a rapid sequence tracheostomy (RST) on rabbit cadaver
Description: The Rapid Sequence Tracheostomy (RST) consists of the following steps:~1. Orientational palpation and vertical midline skin incision followed by separation of the strap muscles~2. Exposure of the trachea and cricoid followed by anterior luxation of the trachea with a Backhaus towel clamp~3. Perform a vertical puncture with a tip scissors between the Cricoid and 1st tracheal ring followed by a vertical incision of no more than 2 rings in length.~4. An age adapted tracheal tube is inserted into the trachea and the lungs are ventilated.
Study: NCT02584881

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: safe opioid prescription protocol
Description: When indicated a prescription for naloxone will be given to patients discharged with prescription opioids from the trauma services. All patients will receive information on safe opioid use and storage and methods for pain management.
Study: NCT04674878

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: METs
Description: The isometric contraction of 7 sec will be applied followed by a stretching of 30 sec in painless range. This treatment will be given to the both sides of the neck targeting the three major accessory muscles of respiration.
Study: NCT00573586

Intervention type: DEVICE
Group type: OTHER
Intervention: Sonablate 500 (SB-500)
Description: Sonablate 500 (SB-500)
Study: NCT03502694

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lumicitabine
Description: Participants will receive loading dose and maintenance dose of lumicitabine tablets orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lumicitabine
Description: Participants will receive loading dose and maintenance dose of lumicitabine tablets orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Participants will receive matching placebo tablets orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Participants will receive matching placebo tablets orally.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants will receive matching placebo tablets orally.
Study: NCT04674878

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Breathing exercise group
Description: Three exercises will be performed in a circuit, 2 circuits in every session. It will include diaphragmatic breathing exercise in which patient will be in supine position inhaling through nose and expiration through moth with half closed lips. Second exercise pursed lip breathing also in supine position with the hands on abdomen and then inspiration through nose and expiration through mouth with half closing of lips. Third exercise resisted diaphragmatic breathing also in same pattern as second exercise with an addition of 1 kg weight on abdomen.
Study: NCT03789812

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Manual toothbrush
Description: Soft manual toothbrush (Oral B) will be used to brush occlusal, buccal and lingual teeth surfaces.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Manual toothbrush
Description: Soft manual toothbrush (Oral B) will be used to brush occlusal, buccal and lingual teeth surfaces.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Electric Toothbrush
Description: Electric toothbrush (Jetpik JP210) will be used to brush occlusal, buccal and lingual teeth surfaces.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Electric Toothbrush
Description: Electric toothbrush (Jetpik JP210) will be used to brush occlusal, buccal and lingual teeth surfaces.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Superfloss
Description: Superfloss (Oral B) will be used to clean interproximal teeth surfaces.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Superfloss
Description: Superfloss (Oral B) will be used to clean interproximal teeth surfaces.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Dental Water Jet
Description: Dental water jet (Jetpik JP210) will be used to clean interproximal teeth surfaces.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Dental Water Jet
Description: Dental water jet (Jetpik JP210) will be used to clean interproximal teeth surfaces.